Would anyone like to share his/her experience on siRNA treatment for in-vivo experiment of cancer mouse model particularly for peritoneal cavity? I would like to know how frequent (daily or every 2/3 days) and how long should be treated to get an effect as tumor size using established cell line xenografts . Further, I heard about antisense phosphorothioate oligonucleotides (PTO), so are they better or promising for in-vivo or any other type of siRNA for in-vivo delivery?

Kindly share your experience on this.

More Tushar Tomar's questions See All
Similar questions and discussions